24.100
+0.050
+(0.21%)
At close: April 17 at 4:08:07 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,726,451.261
2,634,910
2,103,438
1,750,116
1,324,427
Cost of Revenue
815,283.987
781,401
656,515
490,370
334,004
Gross Profit
1,911,167.274
1,853,509
1,446,923
1,259,746
990,423
Operating Expense
1,649,879.069
1,415,132
1,226,752
1,032,151
865,078
Operating Income
261,288.205
438,377
220,171
227,595
125,345
Net Non Operating Interest Income Expense
77,105.753
70,436
80,280
93,247
103,554
Pretax Income
520,954.764
508,260
235,726
382,649
257,026
Tax Provision
99,714.584
95,991
45,395
35,366
30,686
Net Income Common Stockholders
446,169.943
416,121
180,470
352,234
230,072
Diluted NI Available to Com Stockholders
446,169.943
416,121
180,470
352,234
230,072
Basic EPS
1.89
1.74
0.74
1.43
0.93
Diluted EPS
1.89
1.74
0.74
1.43
0.93
Basic Average Shares
235,898.137
238,743.591
242,987.885
246,575.291
248,124.811
Diluted Average Shares
235,898.137
238,743.591
242,987.885
246,575.291
248,124.811
Rent Expense Supplemental
--
4,652
4,562
--
--
Total Expenses
2,465,163.056
2,196,533
1,883,267
1,522,521
1,199,082
Net Income from Continuing & Discontinued Operation
446,169.943
416,121
180,470
352,234
230,072
Normalized Income
447,550.932
414,009.800
192,842.117
349,344.744
228,865.911
Interest Income
75,380.025
77,731
87,883
98,210
108,459
Interest Expense
11,146.226
7,295
7,603
4,963
4,905
Net Interest Income
77,105.753
70,436
80,280
93,247
103,554
EBIT
532,100.990
515,555
243,329
387,612
261,931
EBITDA
532,100.990
713,410
447,546
550,449
394,802
Reconciled Cost of Revenue
815,283.987
781,401
656,515
490,370
334,004
Reconciled Depreciation
--
197,855
204,217
162,837
132,871
Net Income from Continuing Operation Net Minority Interest
446,169.943
416,121
180,470
352,234
230,072
Total Unusual Items Excluding Goodwill
-1,707.891
2,600
-15,331
3,182
1,369
Total Unusual Items
-1,707.891
2,600
-15,331
3,182
1,369
Normalized EBITDA
533,808.882
710,810
462,877
547,267
393,433
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-326.903
488.800
-2,958.883
292.744
162.911
12/31/2020 - 4/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2257.HK Sirnaomics Ltd.
2.960
+0.68%
6660.HK AIM Vaccine Co., Ltd.
3.200
-0.31%
RVMDW Revolution Medicines, Inc.
0.0400
-27.54%
2197.HK Clover Biopharmaceuticals, Ltd.
0.196
-2.00%
2157.HK Lepu Biopharma Co., Ltd.
3.960
+2.86%
6160.HK BeiGene, Ltd.
139.700
-0.36%
1177.HK SINO BIOPHARM
3.670
+1.66%
TLX Telix Pharmaceuticals Limited
16.71
+1.03%
RVMD Revolution Medicines, Inc.
36.76
+1.55%
2269.HK WuXi Biologics (Cayman) Inc.
20.500
+1.49%